ArticleJournal for immunotherapy of cancer2026

Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study.

Elizabeth M Gaughan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.